nodes	percent_of_prediction	percent_of_DWPC	metapath
Telbivudine—Cladribine—Fludarabine—lymphatic system cancer	0.471	0.526	CrCrCtD
Telbivudine—Decitabine—Cytarabine—lymphatic system cancer	0.423	0.474	CrCrCtD
Telbivudine—Disease progression—Carmustine—lymphatic system cancer	0.00486	0.0458	CcSEcCtD
Telbivudine—Flank pain—Fludarabine—lymphatic system cancer	0.00411	0.0388	CcSEcCtD
Telbivudine—Hepatitis acute—Methotrexate—lymphatic system cancer	0.00339	0.0319	CcSEcCtD
Telbivudine—Multi-organ failure—Vincristine—lymphatic system cancer	0.00311	0.0293	CcSEcCtD
Telbivudine—Sepsis—Teniposide—lymphatic system cancer	0.00164	0.0154	CcSEcCtD
Telbivudine—Tenderness—Bleomycin—lymphatic system cancer	0.00139	0.0131	CcSEcCtD
Telbivudine—Neutropenia—Teniposide—lymphatic system cancer	0.00111	0.0104	CcSEcCtD
Telbivudine—Neck pain—Carmustine—lymphatic system cancer	0.00107	0.0101	CcSEcCtD
Telbivudine—Neuropathy peripheral—Teniposide—lymphatic system cancer	0.00103	0.00974	CcSEcCtD
Telbivudine—Musculoskeletal pain—Vincristine—lymphatic system cancer	0.00102	0.00965	CcSEcCtD
Telbivudine—Neutropenia—Fludarabine—lymphatic system cancer	0.000972	0.00916	CcSEcCtD
Telbivudine—Upper respiratory tract infection—Fludarabine—lymphatic system cancer	0.000966	0.0091	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.000945	0.0089	CcSEcCtD
Telbivudine—Sepsis—Carmustine—lymphatic system cancer	0.00092	0.00867	CcSEcCtD
Telbivudine—Renal failure—Fludarabine—lymphatic system cancer	0.000911	0.00858	CcSEcCtD
Telbivudine—Neuropathy peripheral—Fludarabine—lymphatic system cancer	0.000909	0.00856	CcSEcCtD
Telbivudine—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.000893	0.00842	CcSEcCtD
Telbivudine—Skin disorder—Mechlorethamine—lymphatic system cancer	0.000886	0.00835	CcSEcCtD
Telbivudine—Sepsis—Mitoxantrone—lymphatic system cancer	0.000856	0.00806	CcSEcCtD
Telbivudine—Hypoaesthesia—Fludarabine—lymphatic system cancer	0.000828	0.0078	CcSEcCtD
Telbivudine—Pharyngitis—Fludarabine—lymphatic system cancer	0.000826	0.00778	CcSEcCtD
Telbivudine—Pain in extremity—Vincristine—lymphatic system cancer	0.000735	0.00692	CcSEcCtD
Telbivudine—Malnutrition—Fludarabine—lymphatic system cancer	0.000724	0.00682	CcSEcCtD
Telbivudine—Chest pain—Teniposide—lymphatic system cancer	0.000702	0.00661	CcSEcCtD
Telbivudine—Muscular weakness—Carmustine—lymphatic system cancer	0.000679	0.0064	CcSEcCtD
Telbivudine—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.000672	0.00633	CcSEcCtD
Telbivudine—Aspartate aminotransferase increased—Vincristine—lymphatic system cancer	0.000662	0.00623	CcSEcCtD
Telbivudine—Thrombocytopenia—Teniposide—lymphatic system cancer	0.000659	0.0062	CcSEcCtD
Telbivudine—Abdominal pain upper—Mitoxantrone—lymphatic system cancer	0.000654	0.00616	CcSEcCtD
Telbivudine—Malaise—Fludarabine—lymphatic system cancer	0.000653	0.00615	CcSEcCtD
Telbivudine—Muscular weakness—Vincristine—lymphatic system cancer	0.000648	0.00611	CcSEcCtD
Telbivudine—Pruritus—Mechlorethamine—lymphatic system cancer	0.000646	0.00608	CcSEcCtD
Telbivudine—Aspartate aminotransferase increased—Mitoxantrone—lymphatic system cancer	0.000645	0.00607	CcSEcCtD
Telbivudine—Cough—Fludarabine—lymphatic system cancer	0.000632	0.00595	CcSEcCtD
Telbivudine—Alanine aminotransferase increased—Mitoxantrone—lymphatic system cancer	0.000631	0.00595	CcSEcCtD
Telbivudine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.000624	0.00588	CcSEcCtD
Telbivudine—Neutropenia—Carmustine—lymphatic system cancer	0.000622	0.00586	CcSEcCtD
Telbivudine—Myalgia—Fludarabine—lymphatic system cancer	0.000617	0.00581	CcSEcCtD
Telbivudine—Arthralgia—Fludarabine—lymphatic system cancer	0.000617	0.00581	CcSEcCtD
Telbivudine—Discomfort—Fludarabine—lymphatic system cancer	0.000609	0.00574	CcSEcCtD
Telbivudine—Hypoaesthesia—Bleomycin—lymphatic system cancer	0.000607	0.00572	CcSEcCtD
Telbivudine—Neutropenia—Vincristine—lymphatic system cancer	0.000594	0.0056	CcSEcCtD
Telbivudine—Renal failure—Carmustine—lymphatic system cancer	0.000583	0.00549	CcSEcCtD
Telbivudine—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.000582	0.00548	CcSEcCtD
Telbivudine—Vomiting—Mechlorethamine—lymphatic system cancer	0.00058	0.00547	CcSEcCtD
Telbivudine—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00058	0.00546	CcSEcCtD
Telbivudine—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.000579	0.00545	CcSEcCtD
Telbivudine—Neutropenia—Mitoxantrone—lymphatic system cancer	0.000578	0.00545	CcSEcCtD
Telbivudine—Rash—Mechlorethamine—lymphatic system cancer	0.000575	0.00542	CcSEcCtD
Telbivudine—Upper respiratory tract infection—Mitoxantrone—lymphatic system cancer	0.000575	0.00542	CcSEcCtD
Telbivudine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.000575	0.00541	CcSEcCtD
Telbivudine—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.000555	0.00523	CcSEcCtD
Telbivudine—Feeling abnormal—Teniposide—lymphatic system cancer	0.000554	0.00522	CcSEcCtD
Telbivudine—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00055	0.00518	CcSEcCtD
Telbivudine—Musculoskeletal stiffness—Methotrexate—lymphatic system cancer	0.000548	0.00516	CcSEcCtD
Telbivudine—Renal failure—Mitoxantrone—lymphatic system cancer	0.000542	0.00511	CcSEcCtD
Telbivudine—Nausea—Mechlorethamine—lymphatic system cancer	0.000542	0.00511	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.000539	0.00507	CcSEcCtD
Telbivudine—Abdominal pain—Teniposide—lymphatic system cancer	0.000532	0.00501	CcSEcCtD
Telbivudine—Body temperature increased—Teniposide—lymphatic system cancer	0.000532	0.00501	CcSEcCtD
Telbivudine—Paraesthesia—Fludarabine—lymphatic system cancer	0.000531	0.005	CcSEcCtD
Telbivudine—Hypoaesthesia—Carmustine—lymphatic system cancer	0.00053	0.00499	CcSEcCtD
Telbivudine—Connective tissue disorder—Carmustine—lymphatic system cancer	0.000523	0.00493	CcSEcCtD
Telbivudine—Dyspepsia—Fludarabine—lymphatic system cancer	0.00052	0.0049	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00051	0.00481	CcSEcCtD
Telbivudine—Fatigue—Fludarabine—lymphatic system cancer	0.00051	0.0048	CcSEcCtD
Telbivudine—Hypoaesthesia—Vincristine—lymphatic system cancer	0.000506	0.00477	CcSEcCtD
Telbivudine—Pain—Fludarabine—lymphatic system cancer	0.000506	0.00476	CcSEcCtD
Telbivudine—Connective tissue disorder—Vincristine—lymphatic system cancer	0.0005	0.00471	CcSEcCtD
Telbivudine—Hepatitis—Mitoxantrone—lymphatic system cancer	0.000495	0.00466	CcSEcCtD
Telbivudine—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000493	0.00464	CcSEcCtD
Telbivudine—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.000491	0.00463	CcSEcCtD
Telbivudine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000487	0.00459	CcSEcCtD
Telbivudine—Asthenia—Teniposide—lymphatic system cancer	0.000483	0.00455	CcSEcCtD
Telbivudine—Malaise—Bleomycin—lymphatic system cancer	0.000479	0.00451	CcSEcCtD
Telbivudine—Pruritus—Teniposide—lymphatic system cancer	0.000476	0.00448	CcSEcCtD
Telbivudine—Body temperature increased—Fludarabine—lymphatic system cancer	0.000467	0.0044	CcSEcCtD
Telbivudine—Malnutrition—Carmustine—lymphatic system cancer	0.000464	0.00437	CcSEcCtD
Telbivudine—Cough—Bleomycin—lymphatic system cancer	0.000463	0.00437	CcSEcCtD
Telbivudine—Diarrhoea—Teniposide—lymphatic system cancer	0.00046	0.00434	CcSEcCtD
Telbivudine—Mediastinal disorder—Vincristine—lymphatic system cancer	0.000458	0.00432	CcSEcCtD
Telbivudine—Chest pain—Bleomycin—lymphatic system cancer	0.000452	0.00426	CcSEcCtD
Telbivudine—Myalgia—Bleomycin—lymphatic system cancer	0.000452	0.00426	CcSEcCtD
Telbivudine—Back pain—Carmustine—lymphatic system cancer	0.000448	0.00422	CcSEcCtD
Telbivudine—Discomfort—Bleomycin—lymphatic system cancer	0.000447	0.00421	CcSEcCtD
Telbivudine—Back pain—Vincristine—lymphatic system cancer	0.000428	0.00403	CcSEcCtD
Telbivudine—Vomiting—Teniposide—lymphatic system cancer	0.000428	0.00403	CcSEcCtD
Telbivudine—Sepsis—Methotrexate—lymphatic system cancer	0.000426	0.00402	CcSEcCtD
Telbivudine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000424	0.004	CcSEcCtD
Telbivudine—Asthenia—Fludarabine—lymphatic system cancer	0.000424	0.004	CcSEcCtD
Telbivudine—Rash—Teniposide—lymphatic system cancer	0.000424	0.004	CcSEcCtD
Telbivudine—Dermatitis—Teniposide—lymphatic system cancer	0.000424	0.00399	CcSEcCtD
Telbivudine—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000422	0.00398	CcSEcCtD
Telbivudine—Headache—Teniposide—lymphatic system cancer	0.000421	0.00397	CcSEcCtD
Telbivudine—Pruritus—Fludarabine—lymphatic system cancer	0.000418	0.00394	CcSEcCtD
Telbivudine—Back pain—Mitoxantrone—lymphatic system cancer	0.000417	0.00393	CcSEcCtD
Telbivudine—Diarrhoea—Fludarabine—lymphatic system cancer	0.000405	0.00381	CcSEcCtD
Telbivudine—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.0004	0.00377	CcSEcCtD
Telbivudine—Nausea—Teniposide—lymphatic system cancer	0.0004	0.00376	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000395	0.00372	CcSEcCtD
Telbivudine—Chest pain—Carmustine—lymphatic system cancer	0.000395	0.00372	CcSEcCtD
Telbivudine—Myalgia—Carmustine—lymphatic system cancer	0.000395	0.00372	CcSEcCtD
Telbivudine—Paraesthesia—Bleomycin—lymphatic system cancer	0.000389	0.00367	CcSEcCtD
Telbivudine—Malaise—Mitoxantrone—lymphatic system cancer	0.000389	0.00366	CcSEcCtD
Telbivudine—Myalgia—Vincristine—lymphatic system cancer	0.000377	0.00355	CcSEcCtD
Telbivudine—Cough—Mitoxantrone—lymphatic system cancer	0.000376	0.00354	CcSEcCtD
Telbivudine—Vomiting—Fludarabine—lymphatic system cancer	0.000376	0.00354	CcSEcCtD
Telbivudine—Rash—Fludarabine—lymphatic system cancer	0.000373	0.00351	CcSEcCtD
Telbivudine—Dermatitis—Fludarabine—lymphatic system cancer	0.000372	0.00351	CcSEcCtD
Telbivudine—Pain—Bleomycin—lymphatic system cancer	0.000371	0.00349	CcSEcCtD
Telbivudine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00037	0.00349	CcSEcCtD
Telbivudine—Headache—Fludarabine—lymphatic system cancer	0.00037	0.00349	CcSEcCtD
Telbivudine—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000367	0.00346	CcSEcCtD
Telbivudine—Chest pain—Mitoxantrone—lymphatic system cancer	0.000367	0.00346	CcSEcCtD
Telbivudine—Myalgia—Mitoxantrone—lymphatic system cancer	0.000367	0.00346	CcSEcCtD
Telbivudine—Discomfort—Mitoxantrone—lymphatic system cancer	0.000363	0.00342	CcSEcCtD
Telbivudine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000357	0.00337	CcSEcCtD
Telbivudine—Nervous system disorder—Vincristine—lymphatic system cancer	0.000354	0.00334	CcSEcCtD
Telbivudine—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000354	0.00333	CcSEcCtD
Telbivudine—Nausea—Fludarabine—lymphatic system cancer	0.000351	0.00331	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000345	0.00325	CcSEcCtD
Telbivudine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000344	0.00324	CcSEcCtD
Telbivudine—Body temperature increased—Bleomycin—lymphatic system cancer	0.000343	0.00323	CcSEcCtD
Telbivudine—Insomnia—Carmustine—lymphatic system cancer	0.000342	0.00322	CcSEcCtD
Telbivudine—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000342	0.00322	CcSEcCtD
Telbivudine—Paraesthesia—Carmustine—lymphatic system cancer	0.00034	0.0032	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000329	0.0031	CcSEcCtD
Telbivudine—Insomnia—Vincristine—lymphatic system cancer	0.000327	0.00308	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000327	0.00308	CcSEcCtD
Telbivudine—Paraesthesia—Vincristine—lymphatic system cancer	0.000324	0.00306	CcSEcCtD
Telbivudine—Pain—Carmustine—lymphatic system cancer	0.000324	0.00305	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00032	0.00302	CcSEcCtD
Telbivudine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000316	0.00298	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000312	0.00294	CcSEcCtD
Telbivudine—Feeling abnormal—Carmustine—lymphatic system cancer	0.000312	0.00294	CcSEcCtD
Telbivudine—Fatigue—Vincristine—lymphatic system cancer	0.000311	0.00293	CcSEcCtD
Telbivudine—Asthenia—Bleomycin—lymphatic system cancer	0.000311	0.00293	CcSEcCtD
Telbivudine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00031	0.00292	CcSEcCtD
Telbivudine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000309	0.00291	CcSEcCtD
Telbivudine—Pain—Vincristine—lymphatic system cancer	0.000309	0.00291	CcSEcCtD
Telbivudine—Pruritus—Bleomycin—lymphatic system cancer	0.000307	0.00289	CcSEcCtD
Telbivudine—Fatigue—Mitoxantrone—lymphatic system cancer	0.000303	0.00286	CcSEcCtD
Telbivudine—Pain—Mitoxantrone—lymphatic system cancer	0.000301	0.00283	CcSEcCtD
Telbivudine—Abdominal pain—Carmustine—lymphatic system cancer	0.000299	0.00282	CcSEcCtD
Telbivudine—Body temperature increased—Carmustine—lymphatic system cancer	0.000299	0.00282	CcSEcCtD
Telbivudine—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000295	0.00278	CcSEcCtD
Telbivudine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000295	0.00278	CcSEcCtD
Telbivudine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00029	0.00273	CcSEcCtD
Telbivudine—Neutropenia—Methotrexate—lymphatic system cancer	0.000288	0.00271	CcSEcCtD
Telbivudine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000288	0.00271	CcSEcCtD
Telbivudine—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000286	0.0027	CcSEcCtD
Telbivudine—Body temperature increased—Vincristine—lymphatic system cancer	0.000286	0.00269	CcSEcCtD
Telbivudine—Abdominal pain—Vincristine—lymphatic system cancer	0.000286	0.00269	CcSEcCtD
Telbivudine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000278	0.00262	CcSEcCtD
Telbivudine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000278	0.00262	CcSEcCtD
Telbivudine—Vomiting—Bleomycin—lymphatic system cancer	0.000276	0.0026	CcSEcCtD
Telbivudine—Rash—Bleomycin—lymphatic system cancer	0.000273	0.00257	CcSEcCtD
Telbivudine—Dermatitis—Bleomycin—lymphatic system cancer	0.000273	0.00257	CcSEcCtD
Telbivudine—Asthenia—Carmustine—lymphatic system cancer	0.000271	0.00256	CcSEcCtD
Telbivudine—Renal failure—Methotrexate—lymphatic system cancer	0.00027	0.00254	CcSEcCtD
Telbivudine—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.00026	0.00245	CcSEcCtD
Telbivudine—Asthenia—Vincristine—lymphatic system cancer	0.000259	0.00244	CcSEcCtD
Telbivudine—Diarrhoea—Carmustine—lymphatic system cancer	0.000259	0.00244	CcSEcCtD
Telbivudine—Nausea—Bleomycin—lymphatic system cancer	0.000257	0.00243	CcSEcCtD
Telbivudine—Asthenia—Mitoxantrone—lymphatic system cancer	0.000252	0.00238	CcSEcCtD
Telbivudine—Dizziness—Carmustine—lymphatic system cancer	0.00025	0.00236	CcSEcCtD
Telbivudine—Diarrhoea—Vincristine—lymphatic system cancer	0.000247	0.00233	CcSEcCtD
Telbivudine—Hepatitis—Methotrexate—lymphatic system cancer	0.000247	0.00232	CcSEcCtD
Telbivudine—Pharyngitis—Methotrexate—lymphatic system cancer	0.000245	0.00231	CcSEcCtD
Telbivudine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000241	0.00227	CcSEcCtD
Telbivudine—Vomiting—Carmustine—lymphatic system cancer	0.000241	0.00227	CcSEcCtD
Telbivudine—Dizziness—Vincristine—lymphatic system cancer	0.000239	0.00225	CcSEcCtD
Telbivudine—Rash—Carmustine—lymphatic system cancer	0.000239	0.00225	CcSEcCtD
Telbivudine—Dermatitis—Carmustine—lymphatic system cancer	0.000238	0.00225	CcSEcCtD
Telbivudine—Headache—Carmustine—lymphatic system cancer	0.000237	0.00223	CcSEcCtD
Telbivudine—Vomiting—Vincristine—lymphatic system cancer	0.00023	0.00216	CcSEcCtD
Telbivudine—Rash—Vincristine—lymphatic system cancer	0.000228	0.00215	CcSEcCtD
Telbivudine—Dermatitis—Vincristine—lymphatic system cancer	0.000228	0.00214	CcSEcCtD
Telbivudine—Headache—Vincristine—lymphatic system cancer	0.000226	0.00213	CcSEcCtD
Telbivudine—Nausea—Carmustine—lymphatic system cancer	0.000225	0.00212	CcSEcCtD
Telbivudine—Vomiting—Mitoxantrone—lymphatic system cancer	0.000224	0.00211	CcSEcCtD
Telbivudine—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000222	0.00209	CcSEcCtD
Telbivudine—Rash—Mitoxantrone—lymphatic system cancer	0.000222	0.00209	CcSEcCtD
Telbivudine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000222	0.00209	CcSEcCtD
Telbivudine—Headache—Mitoxantrone—lymphatic system cancer	0.00022	0.00208	CcSEcCtD
Telbivudine—Malnutrition—Methotrexate—lymphatic system cancer	0.000215	0.00202	CcSEcCtD
Telbivudine—Nausea—Vincristine—lymphatic system cancer	0.000215	0.00202	CcSEcCtD
Telbivudine—Dysgeusia—Methotrexate—lymphatic system cancer	0.00021	0.00198	CcSEcCtD
Telbivudine—Nausea—Mitoxantrone—lymphatic system cancer	0.000209	0.00197	CcSEcCtD
Telbivudine—Back pain—Methotrexate—lymphatic system cancer	0.000208	0.00196	CcSEcCtD
Telbivudine—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000199	0.00188	CcSEcCtD
Telbivudine—Malaise—Methotrexate—lymphatic system cancer	0.000194	0.00182	CcSEcCtD
Telbivudine—Cough—Methotrexate—lymphatic system cancer	0.000187	0.00177	CcSEcCtD
Telbivudine—Arthralgia—Methotrexate—lymphatic system cancer	0.000183	0.00172	CcSEcCtD
Telbivudine—Chest pain—Methotrexate—lymphatic system cancer	0.000183	0.00172	CcSEcCtD
Telbivudine—Myalgia—Methotrexate—lymphatic system cancer	0.000183	0.00172	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000182	0.00171	CcSEcCtD
Telbivudine—Discomfort—Methotrexate—lymphatic system cancer	0.000181	0.0017	CcSEcCtD
Telbivudine—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000172	0.00162	CcSEcCtD
Telbivudine—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000172	0.00162	CcSEcCtD
Telbivudine—Skin disorder—Methotrexate—lymphatic system cancer	0.00017	0.0016	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00016	0.0015	CcSEcCtD
Telbivudine—Insomnia—Methotrexate—lymphatic system cancer	0.000159	0.00149	CcSEcCtD
Telbivudine—Paraesthesia—Methotrexate—lymphatic system cancer	0.000157	0.00148	CcSEcCtD
Telbivudine—Dyspepsia—Methotrexate—lymphatic system cancer	0.000154	0.00145	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000151	0.00143	CcSEcCtD
Telbivudine—Fatigue—Methotrexate—lymphatic system cancer	0.000151	0.00142	CcSEcCtD
Telbivudine—Pain—Methotrexate—lymphatic system cancer	0.00015	0.00141	CcSEcCtD
Telbivudine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000144	0.00136	CcSEcCtD
Telbivudine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000143	0.00135	CcSEcCtD
Telbivudine—Abdominal pain—Methotrexate—lymphatic system cancer	0.000139	0.00131	CcSEcCtD
Telbivudine—Body temperature increased—Methotrexate—lymphatic system cancer	0.000139	0.00131	CcSEcCtD
Telbivudine—Asthenia—Methotrexate—lymphatic system cancer	0.000126	0.00118	CcSEcCtD
Telbivudine—Pruritus—Methotrexate—lymphatic system cancer	0.000124	0.00117	CcSEcCtD
Telbivudine—Diarrhoea—Methotrexate—lymphatic system cancer	0.00012	0.00113	CcSEcCtD
Telbivudine—Dizziness—Methotrexate—lymphatic system cancer	0.000116	0.00109	CcSEcCtD
Telbivudine—Vomiting—Methotrexate—lymphatic system cancer	0.000111	0.00105	CcSEcCtD
Telbivudine—Rash—Methotrexate—lymphatic system cancer	0.000111	0.00104	CcSEcCtD
Telbivudine—Dermatitis—Methotrexate—lymphatic system cancer	0.00011	0.00104	CcSEcCtD
Telbivudine—Headache—Methotrexate—lymphatic system cancer	0.00011	0.00103	CcSEcCtD
Telbivudine—Nausea—Methotrexate—lymphatic system cancer	0.000104	0.000981	CcSEcCtD
